Harvard Bioscience Inc expected to post earnings of 5  cents a share - Earnings Preview

Harvard Bioscience

21/04/2023 17:40

* Harvard Bioscience Inc  HBIO.OQ   HBIO.O  is expected
to show a
rise in quarterly revenue when it reports  results on April 25. 
    * The Holliston Massachusetts-based  company is expected to
report
 a 0.2% increase in revenue to $28.847 million from $28.78
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Harvard Bioscience
Inc is
for earnings of 5 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Harvard
Bioscience Inc is $4​, below​ its last closing price of $4.84.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  0.08        0.03       0.04      Beat    20
 Sep. 30 2022  0.07        0.07       -0.01     Missed  -115
 Jun. 30 2022  0.04        0.06       0.05      Missed  -16.7​
 Mar. 31 2022  0.05        0.05       0.04      Missed  -25
 ​​Dec.        0.08        0.10       0.08      Missed  -20
 31 2021                                                
 Sep. 30 2021  0.06        0.06       0.06      Met     0​
 Jun. 30 2021  0.06        0.06       0.06      Met     -5.3
 Mar. 31 2021  0.03        0.03       0.05      Beat    50
 This summary was machine generated April 21 at 16:40 GMT.  All
figures in US dollars  unless otherwise stated